Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Dr Sara Giammaria
Advertisement
Articles by Dr Sara Giammaria
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
AI-predicted retinal function shows promise in geographic atrophy
2
Mulling over options for mitigating severe vision loss from diabetes
3
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
4
Trehalose-hyaluronate combination aids tear film after eyelid surgery
5